Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Apple Rush Co. Sources Domestic Organic Erythritol Supplier for Its New Light Juices
Apple Rush Co., Inc., has announced that it has sourced a domestic Organic Erythritol Supplier for its upcoming Apple Rush Organic Light Juices.
- Apple Rush Co. Sources Domestic Organic Erythritol Supplier for Its New Light Juices
Apple Rush Co., Inc., has announced that it has sourced a domestic Organic Erythritol Supplier for its upcoming Apple Rush Organic Light Juices.
- Apple Rush Co. Sources Domestic Organic Erythritol Supplier for Its New Light Juices
Apple Rush Co., Inc., has announced that it has sourced a domestic Organic Erythritol Supplier for its upcoming Apple Rush Organic Light Juices.
- Apple Rush Co. Sources Domestic Organic Erythritol Supplier for Its New Light Juices
Apple Rush Co., Inc., has announced that it has sourced a domestic Organic Erythritol Supplier for its upcoming Apple Rush Organic Light Juices.
- Green Solutions for Natural Product Businesses in Asia
Yolanda Che details green solutions for businesses in the Asian Natural Products Industry in this NPIcenter exclusive article.
- Green Solutions for Natural Product Businesses in Asia
Yolanda Che details green solutions for businesses in the Asian Natural Products Industry in this NPIcenter exclusive article.
- Green Solutions for Natural Product Businesses in Asia
Yolanda Che details green solutions for businesses in the Asian Natural Products Industry in this NPIcenter exclusive article.
- Atrium Innovations Joins the Council for Responsible Nutrition
Atrium Innovations Inc., has announced that they have been named among the newest voting members of the Council for Responsible Nutrition.
- Atrium Innovations Joins the Council for Responsible Nutrition
Atrium Innovations Inc., has announced that they have been named among the newest voting members of the Council for Responsible Nutrition.
- Atrium Innovations Joins the Council for Responsible Nutrition
Atrium Innovations Inc., has announced that they have been named among the newest voting members of the Council for Responsible Nutrition.
- Atrium Innovations Joins the Council for Responsible Nutrition
Atrium Innovations Inc., has announced that they have been named among the newest voting members of the Council for Responsible Nutrition.
- Atrium Innovations Joins the Council for Responsible Nutrition
Atrium Innovations Inc., has announced that they have been named among the newest voting members of the Council for Responsible Nutrition.
- Atrium Innovations Joins the Council for Responsible Nutrition
Atrium Innovations Inc., has announced that they have been named among the newest voting members of the Council for Responsible Nutrition.
- Gift of Hope, Inc., Charity of National Enzyme Company, Hires New Director
Gift of Hope, Inc., a charity started by the owners and employees of National Enzyme Company, has named Meghan Connell their new Director.
- Gift of Hope, Inc., Charity of National Enzyme Company, Hires New Director
Gift of Hope, Inc., a charity started by the owners and employees of National Enzyme Company, has named Meghan Connell their new Director.
- Gift of Hope, Inc., Charity of National Enzyme Company, Hires New Director
Gift of Hope, Inc., a charity started by the owners and employees of National Enzyme Company, has named Meghan Connell their new Director.
- Gift of Hope, Inc., Charity of National Enzyme Company, Hires New Director
Gift of Hope, Inc., a charity started by the owners and employees of National Enzyme Company, has named Meghan Connell their new Director.
- Gift of Hope, Inc., Charity of National Enzyme Company, Hires New Director
Gift of Hope, Inc., a charity started by the owners and employees of National Enzyme Company, has named Meghan Connell their new Director.
- Cargill Joint Venture Nears Completion of New Arachidonic Acid-Rich Oil Production Facility
Cargill has announced that, Cargill Alking Bioengineering (Hubei) Co., Ltd., a joint venture between Cargill and Alking Bioengineering, is nearing completion of a new facility for the production of arachidonic acid-rich oil .
- Cargill Joint Venture Nears Completion of New Arachidonic Acid-Rich Oil Production Facility
Cargill has announced that, Cargill Alking Bioengineering (Hubei) Co., Ltd., a joint venture between Cargill and Alking Bioengineering, is nearing completion of a new facility for the production of arachidonic acid-rich oil .
- Cargill Joint Venture Nears Completion of New Arachidonic Acid-Rich Oil Production Facility
Cargill has announced that, Cargill Alking Bioengineering (Hubei) Co., Ltd., a joint venture between Cargill and Alking Bioengineering, is nearing completion of a new facility for the production of arachidonic acid-rich oil .
- Mannatech Reports FY09 Q3 Results
Mannatech, Incorporated, has announced their FY09 Q3 results, reporting a net loss of $9.2 million or $0.35 per diluted share for the third quarter ending September 30, 2009, compared to a net loss of $0.4 million or $0.02 per diluted share for the third quarter of 2008.
- Mannatech Reports FY09 Q3 Results
Mannatech, Incorporated, has announced their FY09 Q3 results, reporting a net loss of $9.2 million or $0.35 per diluted share for the third quarter ending September 30, 2009, compared to a net loss of $0.4 million or $0.02 per diluted share for the third quarter of 2008.
- Mannatech Reports FY09 Q3 Results
Mannatech, Incorporated, has announced their FY09 Q3 results, reporting a net loss of $9.2 million or $0.35 per diluted share for the third quarter ending September 30, 2009, compared to a net loss of $0.4 million or $0.02 per diluted share for the third quarter of 2008.
- New Partnerships Launch OYC Americas' Entrance into Health Supplement Market
OYC Americas announced today that it has partnered with two reputable makers of health supplements to expand its offerings.
- New Partnerships Launch OYC Americas' Entrance into Health Supplement Market
OYC Americas announced today that it has partnered with two reputable makers of health supplements to expand its offerings.
- New Partnerships Launch OYC Americas' Entrance into Health Supplement Market
OYC Americas announced today that it has partnered with two reputable makers of health supplements to expand its offerings.
- 25+ Year Industry Veteran Joins Stauber Sales Force
Stauber Performance Ingredients, Inc., has announced the addition of Joanne Van Hook to its Account Executive Team.
- 25+ Year Industry Veteran Joins Stauber Sales Force
Stauber Performance Ingredients, Inc., has announced the addition of Joanne Van Hook to its Account Executive Team.
- 25+ Year Industry Veteran Joins Stauber Sales Force
Stauber Performance Ingredients, Inc., has announced the addition of Joanne Van Hook to its Account Executive Team.
- 25+ Year Industry Veteran Joins Stauber Sales Force
Stauber Performance Ingredients, Inc., has announced the addition of Joanne Van Hook to its Account Executive Team.
- 25+ Year Industry Veteran Joins Stauber Sales Force
Stauber Performance Ingredients, Inc., has announced the addition of Joanne Van Hook to its Account Executive Team.
- B&D Nutritional Ingredients Signs Distributor Agreement with Solazyme, Inc.
B&D Nutritional Ingredients, Inc., has announced a strategic relationship with Solazyme Health Sciences, a business unit of Solazyme Inc. Under a distribution agreement, B&D Nutritional Ingredients will promote and distribute Solazyme Golden Chlorella™ products to enhance a new generation of functional foods and dietary supplements.
- B&D Nutritional Ingredients Signs Distributor Agreement with Solazyme, Inc.
B&D Nutritional Ingredients, Inc., has announced a strategic relationship with Solazyme Health Sciences, a business unit of Solazyme Inc. Under a distribution agreement, B&D Nutritional Ingredients will promote and distribute Solazyme Golden Chlorella™ products to enhance a new generation of functional foods and dietary supplements.
- B&D Nutritional Ingredients Signs Distributor Agreement with Solazyme, Inc.
B&D Nutritional Ingredients, Inc., has announced a strategic relationship with Solazyme Health Sciences, a business unit of Solazyme Inc. Under a distribution agreement, B&D Nutritional Ingredients will promote and distribute Solazyme Golden Chlorella™ products to enhance a new generation of functional foods and dietary supplements.
- Melvita, France's Leading Organic Beauty Brand, Debuts in U.S.
Melvita has announced their launch in the United States with a full-service e-commerce site.
- Melvita, France's Leading Organic Beauty Brand, Debuts in U.S.
Melvita has announced their launch in the United States with a full-service e-commerce site.
- Melvita, France's Leading Organic Beauty Brand, Debuts in U.S.
Melvita has announced their launch in the United States with a full-service e-commerce site.
- Vitamin Shoppe, Inc. Announces FY09 Q3 Earnings
Vitamin Shoppe, Inc., has announced their FY09 Q3 results, reporting store sales increased 4.4%.
- Vitamin Shoppe, Inc. Announces FY09 Q3 Earnings
Vitamin Shoppe, Inc., has announced their FY09 Q3 results, reporting store sales increased 4.4%.
- Vitamin Shoppe, Inc. Announces FY09 Q3 Earnings
Vitamin Shoppe, Inc., has announced their FY09 Q3 results, reporting store sales increased 4.4%.
- Continued Growth for Chr. Hansen
Chr. Hansen has announced over the last year their revenue increased by 10% in local currencies and the earnings reached 30.3%.
- Continued Growth for Chr. Hansen
Chr. Hansen has announced over the last year their revenue increased by 10% in local currencies and the earnings reached 30.3%.
- Continued Growth for Chr. Hansen
Chr. Hansen has announced over the last year their revenue increased by 10% in local currencies and the earnings reached 30.3%.
- Jeffrey Dunn Joins Herbalife Board
Herbalife Ltd., has announced that Jeffrey T. Dunn has joined its board of directors.
- Jeffrey Dunn Joins Herbalife Board
Herbalife Ltd., has announced that Jeffrey T. Dunn has joined its board of directors.
- Jeffrey Dunn Joins Herbalife Board
Herbalife Ltd., has announced that Jeffrey T. Dunn has joined its board of directors.
- Jeffrey Dunn Joins Herbalife Board
Herbalife Ltd., has announced that Jeffrey T. Dunn has joined its board of directors.
- Jeffrey Dunn Joins Herbalife Board
Herbalife Ltd., has announced that Jeffrey T. Dunn has joined its board of directors.
- Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health
Star Scientific, Inc., has announced today that the company plans to introduce the CigRx(TM) nutraceutical product developed by its subsidiary, Rock Creek Pharmaceuticals, for worldwide marketing and sales in partnership with inVentiv Health, Inc. inVentiv Health offers a complete range of commercialization solutions for every stage of the product lifecycle, in a range of healthcare categories that includes nutraceutical products.
- Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health
Star Scientific, Inc., has announced today that the company plans to introduce the CigRx(TM) nutraceutical product developed by its subsidiary, Rock Creek Pharmaceuticals, for worldwide marketing and sales in partnership with inVentiv Health, Inc. inVentiv Health offers a complete range of commercialization solutions for every stage of the product lifecycle, in a range of healthcare categories that includes nutraceutical products.
- Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health
Star Scientific, Inc., has announced today that the company plans to introduce the CigRx(TM) nutraceutical product developed by its subsidiary, Rock Creek Pharmaceuticals, for worldwide marketing and sales in partnership with inVentiv Health, Inc. inVentiv Health offers a complete range of commercialization solutions for every stage of the product lifecycle, in a range of healthcare categories that includes nutraceutical products.
- Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health
Star Scientific, Inc., has announced today that the company plans to introduce the CigRx(TM) nutraceutical product developed by its subsidiary, Rock Creek Pharmaceuticals, for worldwide marketing and sales in partnership with inVentiv Health, Inc. inVentiv Health offers a complete range of commercialization solutions for every stage of the product lifecycle, in a range of healthcare categories that includes nutraceutical products.
- Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health
Star Scientific, Inc., has announced today that the company plans to introduce the CigRx(TM) nutraceutical product developed by its subsidiary, Rock Creek Pharmaceuticals, for worldwide marketing and sales in partnership with inVentiv Health, Inc. inVentiv Health offers a complete range of commercialization solutions for every stage of the product lifecycle, in a range of healthcare categories that includes nutraceutical products.
- CP Kelco Begins Production at New Facility and Introduces MAJOL(R) CMC
CP Kelco has announced the completion of its newest hydrocolloid facility in Taixing, China. The facility complies with China Food GMP standards, and has the flexibility to produce carboxymethyl cellulose (CMC) for the food, paper, oilfield and industrial markets.
- CP Kelco Begins Production at New Facility and Introduces MAJOL(R) CMC
CP Kelco has announced the completion of its newest hydrocolloid facility in Taixing, China. The facility complies with China Food GMP standards, and has the flexibility to produce carboxymethyl cellulose (CMC) for the food, paper, oilfield and industrial markets.
- CP Kelco Begins Production at New Facility and Introduces MAJOL(R) CMC
CP Kelco has announced the completion of its newest hydrocolloid facility in Taixing, China. The facility complies with China Food GMP standards, and has the flexibility to produce carboxymethyl cellulose (CMC) for the food, paper, oilfield and industrial markets.
- CP Kelco Begins Production at New Facility and Introduces MAJOL(R) CMC
CP Kelco has announced the completion of its newest hydrocolloid facility in Taixing, China. The facility complies with China Food GMP standards, and has the flexibility to produce carboxymethyl cellulose (CMC) for the food, paper, oilfield and industrial markets.
- CP Kelco Begins Production at New Facility and Introduces MAJOL(R) CMC
CP Kelco has announced the completion of its newest hydrocolloid facility in Taixing, China. The facility complies with China Food GMP standards, and has the flexibility to produce carboxymethyl cellulose (CMC) for the food, paper, oilfield and industrial markets.
- CP Kelco Begins Production at New Facility and Introduces MAJOL(R) CMC
CP Kelco has announced the completion of its newest hydrocolloid facility in Taixing, China. The facility complies with China Food GMP standards, and has the flexibility to produce carboxymethyl cellulose (CMC) for the food, paper, oilfield and industrial markets.
- CP Kelco Begins Production at New Facility and Introduces MAJOL(R) CMC
CP Kelco has announced the completion of its newest hydrocolloid facility in Taixing, China. The facility complies with China Food GMP standards, and has the flexibility to produce carboxymethyl cellulose (CMC) for the food, paper, oilfield and industrial markets.
- ProChon Biotech Selects Lonza to Locally Manufacture Critical Component of BioCart(TM)
ProChon Biotech, Ltd., has announced that it selected Lonza's Hopkinton, Mass. facility to manufacture its proprietary fibroblast growth factor (FGF2v) variant in the United States.
- ProChon Biotech Selects Lonza to Locally Manufacture Critical Component of BioCart(TM)
ProChon Biotech, Ltd., has announced that it selected Lonza's Hopkinton, Mass. facility to manufacture its proprietary fibroblast growth factor (FGF2v) variant in the United States.
- ProChon Biotech Selects Lonza to Locally Manufacture Critical Component of BioCart(TM)
ProChon Biotech, Ltd., has announced that it selected Lonza's Hopkinton, Mass. facility to manufacture its proprietary fibroblast growth factor (FGF2v) variant in the United States.
- Nutrition 21 Announces FY10 Q1 Results
Nutrition 21, Inc., has announced their FY10 Q1 results, reporting total revenues of $4.6 million for the first quarter ended September 30, 2009, compared to $12.7 million in the corresponding quarter a year ago.
- Nutrition 21 Announces FY10 Q1 Results
Nutrition 21, Inc., has announced their FY10 Q1 results, reporting total revenues of $4.6 million for the first quarter ended September 30, 2009, compared to $12.7 million in the corresponding quarter a year ago.
- Nutrition 21 Announces FY10 Q1 Results
Nutrition 21, Inc., has announced their FY10 Q1 results, reporting total revenues of $4.6 million for the first quarter ended September 30, 2009, compared to $12.7 million in the corresponding quarter a year ago.
- Herbalife Opens New Markets in Vietnam and Paraguay
Herbalife Ltd., has announced that it has begun operations in Vietnam, making this the 71st country where the company conducts business. On November 16, operations will begin in Paraguay.
- Herbalife Opens New Markets in Vietnam and Paraguay
Herbalife Ltd., has announced that it has begun operations in Vietnam, making this the 71st country where the company conducts business. On November 16, operations will begin in Paraguay.
- Herbalife Opens New Markets in Vietnam and Paraguay
Herbalife Ltd., has announced that it has begun operations in Vietnam, making this the 71st country where the company conducts business. On November 16, operations will begin in Paraguay.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- New Company for “Change-The-World” Entrepreneurs™ Launches
- GMP Labs Expands Liquid Nutraceutical Capabilities
- What Parents Should Know About Kids and Supplements
- What Parents Should Know About Kids and Supplements
- Oats Beat Back Cholesterol
- Oats Beat Back Cholesterol
- Seniors: Pump Up for Strong Bones and Heart
- Seniors: Pump Up for Strong Bones and Heart
|
Vitacost.com, Inc., a leading online retailer and direct marketer of health and wellness products, today reported financial results for the third quarter and nine-month periods ended September 30, 2009.
Third Quarter of 2009 Operating Highlights Include:
-- Net Sales increased 32% to $48.4 million, compared to $36.7 million for the third quarter of 2008
-- Active customer base (1) expanded to over 1 million customers during the quarter
-- Gross Profit Margin Increased 720 basis points to 31.2% from the prior year period
-- Pro Forma Operating Margins improved to 8.7% compared to 0.1% in the prior year period
-- Adjusted EBITDA improved to $5.1 million, a 465% increase
-- Pro Forma Net Income increased to $3.1 million or $0.13 Per Fully Diluted Share, calculated on weighted average of 23.7 million shares outstanding, excluding $10.9 million of a one-time IPO related non-cash compensation
Three Month Results
For the third quarter, net sales increased 32% to $48.4 million from net sales of $36.7 million for the third quarter of the prior year. Both of the Company's primary sales categories, propriety and third party products, contributed to this strong year-over-year increase by generating record third quarter results.
Gross profit for the third quarter increased 71% to $15.1 million, compared to $8.8 million in the third quarter of the prior year. The Company's gross profit margin increased to 31.2% in the third quarter versus 24.0% in the third quarter of the prior year. Overall, gross profit margins improved by 720 basis points primarily due to transitioning manufacturing of proprietary capsules and tablets from third-party manufacturers to in-house manufacturing, increased purchasing power due to higher sales volume of third-party product, and the raw materials used for manufacturing our proprietary products.
Pro forma operating income for the third quarter was $4.2 million compared to $0.1 million in the same period a year ago. The Company's pro forma operating margin expanded to 8.7% from 0.0% for the same period last year. This improvement was due to strong net sales growth, leverage of sales and marketing expense, and the strength of the Company's proven business model. The company's GAAP operating loss, which includes a $10.9 million one-time non-cash stock-based compensation expense in connection with the recent initial public offering, was $(6.7) million in the third quarter of 2009 compared with $0.1 million in the third quarter of 2008.
Adjusted EBITDA (earnings before interest, taxes, depreciation, amortization and related non-cash compensation expense) for the third quarter of 2009 was $5.1 million, compared to $0.9 million in the previous year.
Pro Forma net income for the third quarter of 2009 was $3.1 million, or $0.13 per diluted share calculated on a weighted average fully diluted share count of 23.7 million shares, versus a net loss of $(0.1) million, or $(0.01) per diluted share, for the comparable period last year. The Company's GAAP net loss, which includes the $10.9 million one-time non-cash stock-based compensation expense in connection with the recent initial public offering, was $(3.8) million in the third quarter of 2009 or $(0.17) per diluted share, compared with a net loss of $(0.1) million or $(0.01) per diluted share in the third quarter of 2008.
"We are extremely pleased with our top-line growth, operating and manufacturing improvements, and strong operating cash flow for the third quarter and first nine months of this year. Third quarter net sales increased in our two primary net sales sources -- third party products and propriety products -- underscoring our expanding product offering as well as customer growth. Notably, both our propriety and third party sales achieved record results, driven by many factors including our superior customer value, product selection, and experience," said Ira Kerker, Vitacost's Chief Executive Officer. "Our business is well positioned for long-term profitable growth and margin expansion even as we continue to invest in our information technology and marketing strategies. Customer acquisition cost was $12.68 for the quarter and by offering the best value, superior customer service and timely and accurate delivery of leading products we expect our active customer base of over 1 million customers to continue growing for many years to come."
Nine Month Results
For the nine months ended September 30, 2009, net sales increased 34% to $141.5 million compared to $105.4 million in the same period last year.
Pro Forma operating income for the nine months ended September 30, 2009 improved to $16.1 million compared to $1.1 million in the same period last year. GAAP operating income, which includes the $10.9 million one-time non-cash stock-based compensation expense in connection with the recent initial public offering, was $5.2 million compared to $1.1 million in the same period last year.
Operating cash flow was $14.3 million for the nine months compared to a $(0.9) million for the previous year nine-months and Adjusted EBITDA for the nine-months was $19.0 million compared to $3.4 million in the same period last year.
Free cash flow was $8.2 million for the nine months ended September 30, 2009 compared to $(5.5) million last year. (Free cash flow is calculated using net cash provided by operating activities less capital expenditures for property, plant and equipment).
Pro forma net income was $10.3 million, or $0.44 per diluted share, compared to net income of $0.6 million, or $0.02 per diluted share, in the same period last year. The Company's GAAP net income, which includes the $10.9 million one-time non-cash stock-based compensation expense in connection with the recent initial public offering, was $3.3 million or $0.14 per fully diluted share for the first nine months of 2009 compared with net income of $0.6 million or $0.02 per fully diluted share for the first nine months of 2008.
Successful Initial Public Offering
On September 24, 2009, the Company completed an initial public offering of its common stock at $12.00 per share and raised $132 million. The Company received approximately $47.1 million in net proceeds. The net proceeds to the Company from this offering are being used to repay existing indebtedness, approximately $20 million to fund capital expenditures such as purchasing fulfillment and manufacturing equipment and retrofitting and expanding the manufacturing and distribution facilities; and the balance for working capital, reducing notes payables and general corporate purposes.
Richard Smith, Chief Financial Officer, commented, "Our recent initial public offering combined with over $14.3 million of operating cash flow for the first nine months of this year enables us to complete our manufacturing expansion and continued investments in technological infrastructure. Our growing active customer base of over 1 million customers and the strength of our balance sheet have us well positioned for many years of future growth."
Balance Sheet
The Company ended the third quarter of 2009 with cash and cash equivalents of $48.4 million as of September 30, 2009. As of September 30, 2009, the Company had $7.7 million of notes payable.
Outlook
For the fourth quarter of 2009, the Company anticipates revenue of $48.0 to 49.0 million. Earnings per diluted share for the fourth quarter are expected to be in the range of $0.07 to $0.08. Weighted average shares for diluted EPS in the fourth quarter of 2009 are estimated to be approximately 29.5 million shares, compared to 23.7 million shares at the end of the third quarter 2009, primarily resulting from the issuance of shares in the Company's IPO.
For the full year ending December 31, 2009, the Company expects revenue of $189.5 to $190.5 million and pro forma earnings per diluted share of $0.50 to $0.51, excluding the non-cash stock-based compensation expense in connection with the recent IPO outlined above. Weighted average shares used to calculate diluted earnings per share for the full year ending December 31, 2009 are estimated to be approximately 25.1 million shares.
Conference Call Information
The Company will also host a conference call today, November 4, 2009, to discuss these results with additional comments and details. Participating on the call will be Ira Kerker, Chief Executive Officer, and Richard Smith, Chief Financial and Accounting Officer.
The conference call is scheduled to begin at 8:30 a.m. EDT on November 4, 2009. The call will be broadcast live over the Internet hosted at the Investor Relations section of Vitacost.com, Inc.'s website at www.vitacost.com, and will be archived online within one hour of its completion and continue through November 18, 2009. In addition, you may dial (877) 407-0789 to listen to the live broadcast.
A telephonic playback will be available from 11:30 a.m. EDT, November 4, 2009, through November 18, 2009. Participants can dial (877) 660-6853 to hear the playback. The account number is 3055 and the passcode is 335652 to hear the playback.
About Vitacost.com, Inc.
Vitacost.com, Inc. (Symbol: VITC) is a leading online retailer and direct marketer of health and wellness products, including dietary supplements such as vitamins, minerals, herbs or other botanicals, amino acids and metabolites, as well as cosmetics, organic body and personal care products, sports nutrition and health foods. Vitacost.com, Inc. sells these products directly to consumers through its website, www.vitacost.com, as well as through its catalogs. Vitacost.com, Inc. strives to offer its customers the broadest product selection supported by current scientific and medical research at the best value, while providing superior customer service and timely and accurate delivery.
Forward-Looking Statements
Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made herein, which include management's plans with respect to the use of proceeds from the Company's initial public offering and statements regarding the Company's expected results of operations for the fourth quarter of 2009 and the full year of 2010, involve known and unknown risks and uncertainties, which may cause Vitacost's actual results in current or future periods to differ materially from forecasted results. Those risks and uncertainties include, among other things, the current global economic downturn or recession; difficulty expanding its manufacturing and distribution facilities; significant competition in its industry; unfavorable publicity or consumer perception of its products on the Internet; the incurrence of material product liability and product recall costs; Inability to defend intellectual property claims; costs of compliance and its failure to comply with government regulations; its failure to keep pace with the demands of our customers for new products; disruptions in its manufacturing system, including information technology systems, or losses of manufacturing certifications; and the lack of long-term experience with human consumption of some of its products with innovative ingredients. Those and other risks are more fully described in Vitacost's filings with the Securities and Exchange Commission, including the Registration Statement on Form S-1, as amended, filed in connection with the Company's initial public offering.
1. Definition of active customers, Active customer base: defined as customers who have purchased from Vitacost.com within the last 12 months. |